FDA Questions Delay Approval of Human Genome Sciences Anthrax Drug Raxibacumab
Links shared publicly online about this topic
FDA questions delay approval of Human Genome Sciences anthrax drug raxibacumab - washingtonpost.com
washingtonpost.com — “anthrax treatment delayed by FDA” View full resource at washingtonpost.com
Most Recently Shared on November 16, 2009 at 11:28 pm By:
FDA delays approval of Rockville company's anthrax drug - Washington Post http://ow.ly/1628yh
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Health Feed
Heath News & Information
Advertisement
